Evidence map›Paper›PMID 35008917›Full record

ReviewInternational journal of molecular sciences2022

Modulation of Ubiquitin Signaling in Innate Immune Response by Herpesviruses.

Sandrine-M Soh, Yeong-Jun Kim, Hong-Hee Kim, Hye-Ra Lee

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Unlocking STING as a Therapeutic Antiviral Strategy.International journal of molecular sciences · 2023
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sandrine-M SohDepartment of Biotechnology and Bioinformatics, College of Science and Technology, Korea University, Sejong 30019, Korea.
Yeong-Jun KimDepartment of Biotechnology and Bioinformatics, College of Science and Technology, Korea University, Sejong 30019, Korea.
Hong-Hee KimDepartment of Biotechnology and Bioinformatics, College of Science and Technology, Korea University, Sejong 30019, Korea.
Hye-Ra LeeDepartment of Biotechnology and Bioinformatics, College of Science and Technology, Korea University, Sejong 30019, Korea.ORCID 0000-0003-3815-3291
Korea University · KR

Funding

National Research Foundation of Korea 2019R1A2C1008512
6 · The paper itself

Abstract

The ubiquitin proteasome system (UPS) is a protein degradation machinery that is crucial for cellular homeostasis in eukaryotes. Therefore, it is not surprising that the UPS coordinates almost all host cellular processes, including host-pathogen interactions. This protein degradation machinery acts predominantly by tagging substrate proteins designated for degradation with a ubiquitin molecule. These ubiquitin tags have been involved at various steps of the innate immune response. Hence, herpesviruses have evolved ways to antagonize the host defense mechanisms by targeting UPS components such as ubiquitin E3 ligases and deubiquitinases (DUBs) that establish a productive infection. This review delineates how herpesviruses usurp the critical roles of ubiquitin E3 ligases and DUBs in innate immune response to escape host-antiviral immune response, with particular focus on retinoic acid-inducible gene I (RIG-I)-like receptors (RLR), cyclic-GMP-AMP (cGAMP) synthase (cGAS), stimulator of interferon (IFN) genes (STING) pathways, and inflammasome signaling.

Indexed as

Immunity, InnateSignal TransductionAnimalsHerpesviridaeHumansImmunologic FactorsInflammationUbiquitinImmunologic FactorsUbiquitindeubiquitinasesherpesviruseshost-antiviral immune responseinnate immunityubiquitin E3 ligases

Identifiers

PMID35008917
PMCPMC8745310
OpenAlexW4205748057

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.